Your browser doesn't support javascript.
loading
The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial.
BMC Womens Health ; 12: 22, 2012 Aug 08.
Article em En | MEDLINE | ID: mdl-22873367
ABSTRACT

BACKGROUND:

In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30%. Studies have shown that minor intrauterine abnormalities can be found in 11-45% of infertile women with a normal transvaginal sonography or hysterosalpingography. Two randomised controlled trials have indicated that detection and treatment of these abnormalities by office hysteroscopy after two failed IVF cycles leads to a 9-13% increase in pregnancy rate. Therefore, screening of all infertile women for intracavitary pathology prior to the start of IVF/ICSI is increasingly advocated. In absence of a scientific basis for such a policy, this study will assess the effects and costs of screening for and treatment of unsuspected intrauterine abnormalities by routine office hysteroscopy, with or without saline infusion sonography (SIS), prior to a first IVF/ICSI cycle. METHODS/

DESIGN:

Multicenter randomised controlled trial in asymptomatic subfertile women, indicated for a first IVF/ICSI treatment cycle, with normal findings at transvaginal sonography. Women with recurrent miscarriages, prior hysteroscopy treatment and intermenstrual blood loss will not be included. Participants will be randomised for a routine fertility work-up with additional (SIS and) hysteroscopy with on-the-spot-treatment of predefined intrauterine abnormalities versus the regular fertility work-up without additional diagnostic tests. The primary study outcome is the cumulative ongoing pregnancy rate resulting in live birth achieved within 18 months of IVF/ICSI treatment after randomisation. Secondary study outcome parameters are the cumulative implantation rate; cumulative miscarriage rate; patient preference and patient tolerance of a SIS and hysteroscopy procedure. All data will be analysed according to the intention-to-treat principle, using univariate and multivariate logistic regression and cox regression. Cost-effectiveness analysis will be performed to evaluate the costs of the additional tests as routine procedure. In total 700 patients will be included in this study.

DISCUSSION:

The results of this study will help to clarify the significance of hysteroscopy prior to IVF treatment. TRIAL REGISTRATION NCT01242852.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Uterinas / Útero / Fertilização in vitro / Histeroscopia / Infertilidade Feminina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Uterinas / Útero / Fertilização in vitro / Histeroscopia / Infertilidade Feminina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article